☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Jacobus Pharmaceutical's Ruzurgi (amifampridine) Receives the US FDA's Approval for Lambert-Eaton myasthenic syndrome
May 6, 2019
Roche's Kadcyla (trastuzumab emtansine) Receives FDA's Expanded Approval as an Adjuvant Treatment for HER2+ Early Breast Cancer in...
May 6, 2019
Lundbeck to Acquire Abide Therapeutics for $400M
May 6, 2019
Astellas Reports Results of Mirabegron in P-IV PLUS Study to Reduce Overactive Bladder Symptoms in Men
May 6, 2019
Pfizer's Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) Receive FDA's Approval for Transthyretin Amyloid Cardiomyopathy
May 6, 2019
PharmaShots Weekly Snapshot (April 29-May 03, 2019)
May 6, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions